Trademarkia Logo

Australia

AU$
CYTEGRITY
Published: Under examination

Last updated on 18 Jun 2024

Owner Info

CSL Behring Gene Therapy, Inc.

Suite 650,

35 N. Lake Avenue, UNITED STATES OF AMERICA

Serial Number

2457763 filed on 14 Feb 2024

Correspondent

Scott D. Woldow Smith, Gambrell & Russell, LLP

1055 Thomas Jefferson St. NW,,

Suite 400,

UNITED STATES OF AMERICA

CYTEGRITY

Classification Information


Class [040]
Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors; custom manufacturing services of Read More

Class [042]
Scientific, pharmaceutical and medical research and development; biological research; laboratory services in connection with viral vectors and gene th Read More

Class [045]
Regulatory and process pathway consulting for clinical manufacturing.

Mark Details


Serial Number

2457763

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

20 Oct 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
18th Jun 2024Adverse Report (Examination) correspondence sent
17th Jun 2024IP Right has been Examined
13th Jun 2024Awaiting examination
13th Jun 2024Examination expedited
13th Jun 2024IP Right Filed Published
13th Jun 2024Status change to Published
13th Jun 2024Status change to Filed
13th Jun 2024IP right goods and service classes updated
13th Jun 2024IP Right Goods and Services Items updated
13th Jun 2024IP Right Goods and Services Items updated